发明名称 Thiazolopyrimidine Derivative
摘要 The present invention provides a compound represented by the following Formula: wherein A is an aryl group or a heteroaryl group, each of which may be substituted; R<SUP>1 </SUP>is a group which is bonded through carbon; R<SUP>2 </SUP>is hydrogen or an aliphatic hydrocarbon group; and X is -NR<SUP>3</SUP>-, -O-, -S-, -SO-, -SO<SUB>2</SUB>-, or -CHR<SUP>3</SUP>- (wherein R<SUP>3 </SUP>is hydrogen or an aliphatic hydrocarbon group), or a salt thereof, or a prodrug thereof, which has growth factor receptor tyrosine kinase inhibitory activity and low toxicity, and is useful for prevention and treatment of cancer, and thus can be sufficiently used as a medicine.
申请公布号 US2008269238(A1) 申请公布日期 2008.10.30
申请号 US20060547493 申请日期 2006.09.29
申请人 TAKEDA PHARMACEUTICAL COMPANY LIMITED 发明人 SUGIHARA YOSHIHIRO;KAWAKITA YOUICHI
分类号 A61K31/519;A61K31/496;A61P13/08;A61P35/00;A61P43/00;C07D513/04 主分类号 A61K31/519
代理机构 代理人
主权项
地址